Literature DB >> 7611820

Labor induction and augmentation with oxytocin: pharmacokinetic considerations.

M Gonser1.   

Abstract

Traditional protocols for oxytocin infusion regimens recommend increases of infusion rate at 15-20 min intervals. However recent clinical studies agree that prolonged intervals of 30-40 or even 60 minutes are superior to shorter dosage intervals in terms of safety and efficacy. These results are in good agreement with recent pharmacologic data on oxytocin in pregnant women, showing a half-life of about 15 minutes, and of current pharmacokinetic principles, which indicate that at least 3 half-lives of constant infusion will elapse before the corresponding clinical effect may be established. Increasing the oxytocin infusion earlier, could cause excessive uterine contractions and fetal distress.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7611820     DOI: 10.1007/BF00634710

Source DB:  PubMed          Journal:  Arch Gynecol Obstet        ISSN: 0932-0067            Impact factor:   2.344


  12 in total

1.  An indirect method for the estimation of oxytocin blood concentration and half-life in pregnant women near term.

Authors:  K SAAMELI
Journal:  Am J Obstet Gynecol       Date:  1963-01-15       Impact factor: 8.661

2.  Oxytocin augmentation of labor: a comparison of 15- and 30-minute dose increment intervals.

Authors:  T C Foster; J D Jacobson; G J Valenzuela
Journal:  Obstet Gynecol       Date:  1988-02       Impact factor: 7.661

3.  Induction of labour. 3. Results with amniotomy and oxytocin "titration".

Authors:  A C Turnbull; A B Anderson
Journal:  J Obstet Gynaecol Br Commonw       Date:  1968-01

4.  Half-life of oxytocin in blood of pregnant and non-pregnant women.

Authors:  G Rydén; I Sjöholm
Journal:  Acta Endocrinol (Copenh)       Date:  1969-07

5.  Incremental increases in oxytocin infusion regimens for induction of labor at term in primigravidas: a randomized controlled trial.

Authors:  A A Orhue
Journal:  Obstet Gynecol       Date:  1994-02       Impact factor: 7.661

6.  Labor induction with continuous low-dose oxytocin infusion: a randomized trial.

Authors:  B Mercer; P Pilgrim; B Sibai
Journal:  Obstet Gynecol       Date:  1991-05       Impact factor: 7.661

7.  High-dose oxytocin: 20- versus 40-minute dosage interval.

Authors:  A J Satin; K J Leveno; M L Sherman; D McIntire
Journal:  Obstet Gynecol       Date:  1994-02       Impact factor: 7.661

8.  Oxytocin augmentation of dysfunctional labor. IV. Oxytocin pharmacokinetics.

Authors:  J Seitchik; J Amico; A G Robinson; M Castillo
Journal:  Am J Obstet Gynecol       Date:  1984-10-01       Impact factor: 8.661

Review 9.  Endocrinology of human parturition: a review.

Authors:  A R Fuchs; F Fuchs
Journal:  Br J Obstet Gynaecol       Date:  1984-10

10.  A prospective comparison of hourly and quarter-hourly oxytocin dose increase intervals for the induction of labor at term.

Authors:  K J Blakemore; N G Qin; R H Petrie; L L Paine
Journal:  Obstet Gynecol       Date:  1990-05       Impact factor: 7.661

View more
  4 in total

1.  Refinement of a protocol for the induction of lactation in nonpregnant nonhuman primates by using exogenous hormone treatment.

Authors:  Shannon D Smith; Joshua D Amos; Krista N Beck; Lisa M Colvin; Kelly S Franke; Brooke E Liebl; Sallie R Permar
Journal:  J Am Assoc Lab Anim Sci       Date:  2014-11       Impact factor: 1.232

2.  Acylated heptapeptide binds albumin with high affinity and application as tag furnishes long-acting peptides.

Authors:  Alessandro Zorzi; Simon J Middendorp; Jonas Wilbs; Kaycie Deyle; Christian Heinis
Journal:  Nat Commun       Date:  2017-07-17       Impact factor: 14.919

Review 3.  Oxytocin for preventing postpartum haemorrhage (PPH) in non-facility birth settings.

Authors:  Tomas Pantoja; Edgardo Abalos; Evelina Chapman; Claudio Vera; Valentina P Serrano
Journal:  Cochrane Database Syst Rev       Date:  2016-04-14

4.  Progesterone inhibits contraction and increases TREK-1 potassium channel expression in late pregnant rat uterus.

Authors:  Zongzhi Yin; Yun Li; Wenzhu He; Dan Li; Hongyan Li; Yuanyuan Yang; Bing Shen; Xi Wang; Yunxia Cao; Raouf A Khalil
Journal:  Oncotarget       Date:  2017-12-07
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.